No Data
No Data
BioAge Labs Price Target Lowered to $5 From $7 at Citi
Cautious Outlook on BioAge Labs Amid Promising Developments and High Risk
BioAge Labs, Inc.: Sell Rating Due to Discontinued Program and Uncertain Prospects
Jefferies Downgrades BioAge Labs(BIOA.US) to Hold Rating, Cuts Target Price to $7
William Blair Sticks to Its Hold Rating for BioAge Labs, Inc. (BIOA)
BioAge Labs | 10-K: FY2024 Annual Report
Unlock the Full List